Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on November 4, 2025. The filing reports the execution of a final extension to consummate its initial business combination with United Hydrogen Group Inc.
Key Financial Metrics
- Extension Payment: $150,000 deposited into the trust account.
- Promissory Note Principal: $150,000 issued to the Sponsor (Aimei Health Ltd) and United Hydrogen Group Inc.
- Interest Rate: 0% (Non-interest bearing).
- Conversion Price: $10.00 per private unit (one ordinary share and one right).
- Liquidity Impact: The filing does not provide broader liquidity metrics, cash flow, or debt totals beyond the specific extension transaction.
Material Changes
The primary material change is the extension of the Termination Date from November 6, 2025, to December 6, 2025. This represents the twelfth and final extension permitted under the Company's Amended and Restated Articles of Association. The Company has incurred a new direct financial obligation via the issuance of the unsecured promissory note.
Outlook, Risks, and Contingencies
- Deadline: The Company must consummate the business combination by December 6, 2025, or face liquidation.
- Repayment Terms: The promissory note principal is due upon the consummation of the business combination.
- Conversion Option: Payees may convert the note into private units prior to closing the business combination.
- Risk: Failure to complete the merger by the new deadline will likely result in the dissolution of the trust and return of funds to public shareholders.
Investor Verification Checklist
- Confirm the exact deadline for the business combination (December 6, 2025).
- Verify the status of the merger agreement with United Hydrogen Group Inc.
- Review the full text of the Promissory Note (Exhibit 10.1) for additional covenants.
- Monitor whether the Payees elect to convert the note into equity or demand repayment upon closing.